# Dapagliflozin Effects on Hypoglycemia

> **NCT03704818** · PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 22 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** Dapagliflozin 5mg
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03704818
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-08
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03704818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03704818, "Dapagliflozin Effects on Hypoglycemia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03704818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*